US Prescription Drug Spending to Top $560bn in 2026
US prescription drug spending is forecast to exceed $560bn in 2026 as demand for GLP-1 obesity and diabetes treatments continues to rise.
US prescription drug spending is forecast to exceed $560bn in 2026 as demand for GLP-1 obesity and diabetes treatments continues to rise.
An alarming investigation has revealed the prevalence of substandard cancer drugs in Africa, putting patients at risk with ineffective treatments.
Young doctors, including those from the state-funded Nelson Mandela-Fidel Castro programme, are unemployed due to severe budget cuts.
Biovac secures a deal with Biological E to produce a pneumonia vaccine in Africa, promoting vaccine independence continent-wide.
Bestmed Medical Scheme is set to deploy AI to combat rampant medical aid fraud and manage soaring healthcare costs.
...